|
|
BioEnterprise is a business formation, recruitment, and acceleration initiative designed to grow health care companies and commercialize bioscience technologies. Based in Cleveland, BioEnterprise's founders and partners are Cleveland Clinic, University Hospitals, Case Western Reserve University, Summa Health System and BioInnovation Institute in Akron. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio. The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices: the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and Summa Enterprise Group. Companies include emerging medical device, biotechnology, and health care services firms. Each year, the BioEnterprise groups choose a select number of companies on which to focus. The resources and networks of the BioEnterprise partners are directed to help those companies achieve greater levels of business success. Since July 2002, the BioEnterprise Initiative has achieved: more than 350 companies created, recruited, and acclerated; more than $2 billion in new funding attracted by these companies; over $210 million in revenues collected by technology offices; and over 1,900 company opportunities and 3,400 invention disclosures.
|
